Isoprenoid formation and cell-mediated immunological functions.
Linna
J
J
E.I. duPont de Nemours & Co., Medical Products Department Experimental Station, Wilmington, Delaware 19880-0400.
Moke
M
M
Chen
H W
HW
D002478:Cells, Cultured; D002784:Cholesterol / Q000096:biosynthesis; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D003864:Depression, Chemical; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007111:Immunity, Cellular / Q000187:drug effects*; D007157:Immunologic Surveillance / Q000187:drug effects; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000187:drug effects* / Q000276:immunology; D007694:Killer Cells, Natural / Q000187:drug effects* / Q000276:immunology; D008148:Lovastatin / Q000494:pharmacology*; D008798:Mevalonic Acid / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D013729:Terpenes; D014407:Tumor Cells, Cultured; D014415:Tunicamycin / Q000494:pharmacology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D007376:Interleukin-2; D011994:Recombinant Proteins; D013729:Terpenes; D014415:Tunicamycin; D002784:Cholesterol; D008148:Lovastatin; D008798:Mevalonic Acid